Breaking News, Financial News

Financial Report: Baxter

Revenues up 16% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Baxter   2Q Revenues: $4.3 billion (+16%) 2Q Earnings: $520 million (-12%) YTD Revenues: $8.2 billion (+15%) YTD Earnings: $1.1 billion (-6%) Comments: BioScience revenues were up 7% to $1.8 billion in the quarter, led by double-digit growth of ADVATE and albumin, as well as increased global demand for GAMMAGARD LIQUID, biosurgery products and select vaccines. Medical Product sales were $2.5 billion, up 24%, driven primarily by strong sales of injectable drugs, anesthetics and nutritional th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters